First, I just want to reply to Dore. I do believe we will see gene therapy cures for Thalassemia, Sickle Cell disease and Pyruvate kinase deficiency. I say this because each one of these has been cured in animal trials and it is only a matter of time before all of these have been trialed in humans. I realize that cures available to the public are still years away but they are coming. I also think that many of the advances in treatment may make a cure less meaningful, as the disorders will become easier to manage as new developments are introduced.
I also want to get back to the discussion about transfusion requirements at low ferritin levels. Lena has not seen any difference. Umair said he has had a longer gap between transfusions. The reason I brought this up, in addition to the material presented here by ironjustice, is that I have indeed heard that in infants who have never been allowed to have any iron load, that less destruction of red blood cells has been observed. There is some thought that by chelating as soon as transfusions begin, that this may work towards lower blood requirements.
I realize that any evidence presented here by patients is anecdotal, but I would like to hear from more patients. Has anyone else noticed a difference in blood requirements once their iron load has dropped to the close-to-normal range? I don't think we'll hear from anyone regarding infants, as this is very new and I don't know if this is actually being tried yet, since most doctors prefer to wait until the child is older before introducing chelation drugs. It may be that the earlier chelation begins, the better off the patient will be in ways that we previously did not consider.